Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate. 1990

H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
Department of Nutrition and Food Science, Veterans Administration Hospital, Lexington, KY.

The purpose of this study was to determine the effect of the dietary antioxidant vitamin E on hepatocarcinogenesis by peroxisome proliferators which, it is hypothesized, induce tumors by increased production of hydrogen peroxide or other oxygen radicals. Rats were fed diets containing the peroxisome proliferator ciprofibrate and one of three concentrations (10, 50, or 500 ppm) of alpha-tocopheryl acetate for 6 months or 21 months. The incidence of hepatic tumors and the number and volume of gamma-glutamyl-transpeptidase-positive, ATPase-negative, glucose-6-phosphatase-negative, and glucose-6-phosphatase-positive foci were quantified. No tumors or altered hepatic foci were seen at 6 months, but at 21 months the incidence of hepatic tumors and the number and volume of altered hepatic foci were increased in rats fed higher levels of vitamin E. Indices of oxidative damage--concentrations of malonaldehyde, conjugated dienes, and lipid-soluble fluorescence products--were not affected or were lower in rats fed higher amounts of vitamin E; the enhancing effect of vitamin E on the development of altered hepatic foci and hepatic tumors, therefore, was not related to the induction of cellular oxidative damage. Hepatic peroxisomal fatty acid beta-oxidation and vitamin C concentrations were not affected by vitamin E, whereas the glutathione concentration was decreased in rats fed higher amounts of vitamin E. This study shows that increasing the vitamin E content of the diet enhances ciprofibrate-induced hepatocarcinogenesis, but the mechanism of this effect is unclear.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D002995 Clofibric Acid An antilipemic agent that is the biologically active metabolite of CLOFIBRATE. Clofibrinic Acid,2-(4-Chlorophenoxy)-2-methylpropionic Acid,NSC-1149,p-Chlorophenoxyisobutyrate,p-Chlorophenoxyisobutyric Acid,NSC 1149,NSC1149
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D005723 gamma-Glutamyltransferase An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid. GGTP,Glutamyl Transpeptidase,gammaglutamyltransferase,gamma-Glutamyl Transpeptidase,Transpeptidase, Glutamyl,Transpeptidase, gamma-Glutamyl,gamma Glutamyl Transpeptidase,gamma Glutamyltransferase
D005952 Glucose-6-Phosphatase An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9. Glucosephosphatase,Glucose 6-Phosphatase,Glucose-6-Phosphate Phosphohydrolase,Glucose 6 Phosphatase
D000251 Adenosine Triphosphatases A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA. ATPases,Adenosinetriphosphatase,ATPase,ATPase, DNA-Dependent,Adenosine Triphosphatase,DNA-Dependent ATPase,DNA-Dependent Adenosinetriphosphatases,ATPase, DNA Dependent,Adenosinetriphosphatases, DNA-Dependent,DNA Dependent ATPase,DNA Dependent Adenosinetriphosphatases,Triphosphatase, Adenosine

Related Publications

H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
February 1998, Toxicology,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
August 2004, Toxicology and applied pharmacology,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
June 1990, Toxicology,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
September 1984, Biochemical and biophysical research communications,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
January 1993, Carcinogenesis,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
June 1998, Scandinavian journal of gastroenterology,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
June 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
January 1994, Carcinogenesis,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
January 1987, Carcinogenesis,
H P Glauert, and M M Beaty, and T D Clark, and W S Greenwell, and V Tatum, and L C Chen, and T Borges, and T L Clark, and S R Srinivasan, and C K Chow
November 1999, Carcinogenesis,
Copied contents to your clipboard!